Home  /  Resource Library  /  Patients with Primary Central Nervous System Lymphoma Not Eligible for Clinical Trials: Prognostic Factors, Treatment and Outcome

Patients with Primary Central Nervous System Lymphoma Not Eligible for Clinical Trials: Prognostic Factors, Treatment and Outcome

Retrospective study examined the role of high dose methotrexate for treatment of primary central nervous system lymphoma.